Form 4: Aptevo Therapeutics Inc. Executive Marvin L. White Reports Stock Transactions
SEC Form 4 Filing
Marvin L. White, President and CEO of Aptevo Therapeutics Inc., reports the acquisition of common stock through the conversion of Restricted Stock Units (RSUs) on March 2nd and 3rd, 2025.
Summary
- Marvin L. White, the President and CEO of Aptevo Therapeutics Inc., filed a Form 4 detailing changes in beneficial ownership.
- On March 2, 2025, White acquired 8 shares of common stock through the conversion of Restricted Stock Units (RSUs).
- On March 3, 2025, White acquired 6 shares of common stock through the conversion of RSUs.
- The RSUs convert into common stock on a one-for-one basis.
- The RSUs were granted on March 3, 2023 (38,750 RSUs vesting annually beginning March 2, 2024) and June 7, 2022 (28,750 RSUs vesting annually beginning March 3, 2023).
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects routine stock transactions related to executive compensation.
Positives
- The acquisition of shares by the CEO could be interpreted positively, indicating confidence in the company's future.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, primarily providing transparency to shareholders regarding executive compensation.
Key Dates
| Date | Description |
|---|---|
| June 7, 2022 | Reporting person was granted 28,750 (18 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023. |
| March 3, 2023 | Reporting person was granted 38,750 (24 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024. |
| March 2, 2024 | First vesting date for RSUs granted on March 3, 2023. |
| March 2, 2025 | Marvin L. White acquired 8 shares of common stock through RSU conversion. |
| March 3, 2025 | Marvin L. White acquired 6 shares of common stock through RSU conversion. |
| March 4, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.